SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-325982
Filing Date
2020-12-23
Accepted
2020-12-23 16:08:28
Documents
3
Period of Report
2020-12-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d205920d8k.htm 8-K 19020
2 EX-99.1 d205920dex991.htm EX-99.1 25507
3 GRAPHIC g205920g1224013607635.jpg GRAPHIC 3381
  Complete submission text file 0001193125-20-325982.txt   50462
Mailing Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617
Business Address 5281 CALIFORNIA AVENUE SUITE 100 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Filer) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38667 | Film No.: 201412333
SIC: 2834 Pharmaceutical Preparations